BIO Briefs Geneva Audience on Science of Human Genome Editing

BIO staff recently traveled to Geneva to brief country missions and representatives from the World Health Organization (WHO), World Trade Organization (WTO) and World Intellectual Property Organization (WIPO) on the science behind developing somatic cell genome editing medicine and its potential treat and cure disease.
Sesquile Ramon, BIO’s Director, Science and Regulatory Affairs discussed advances in human genome editing
Matt O’Mara, BIO’s Vice President of International Affa